While significant progress has been made in understanding the induction of tumor vasculature by secreted angiogenic factors, little is known regarding contact-dependent signals that promote tumor angiogenesis. Here, we report that the Notch ligand Jagged1 induced by growth factors via mitogen-activating protein kinase (MAPK) in head and neck squamous cell carcinoma (HNSCC) cells triggered Notch activation in neighboring endothelial cells (ECs) and promoted capillary-like sprout formation. Jagged1-expressing HNSCC cells significantly enhanced neovascularization and tumor growth in vivo. Moreover, the level of Jagged1 was significantly correlated with tumor blood vessel content and associated with HNSCC development. Our results elucidate a novel mechanism by which the direct interplay between tumor cells and ECs promotes angiogenesis through MAPK and Notch signaling pathways.
cer, demonstrating the potential for cancer therapy based upon Introduction blocking angiogenesis (Ferrara et al., 2004) . However, targeting VEGF for human cancer therapy has not been successful in a Tumor angiogenesis is a complex process in which new blood variety of other tumor types, suggesting that other factors or vessels are formed in response to interactions between tumor components may also play a critical role in tumor angiogenesis cells and endothelial cells (ECs), growth factors, and extracel- (Jung et al., 2002; Kerbel and Kamen, 2004) . The identification lular matrix components. Tumor vessels promote growth and of those factors and components may have important implicaprogression of human solid tumors, including head and neck tions in human cancer therapy. squamous cell carcinoma (HNSCC). New tumor blood vessels Angiogenic growth factors secreted by tumor cells or tumor penetrate into cancerous growths, supplying nutrients and oxstromal cells can directly bind to their receptors on ECs and ygen and removing waste products (Jung et al., 2002; Folk- stimulate angiogenesis by promoting endothelial sprouting, man, 2002; Kerbel and Kamen, 2004; Stupack and Cheresh, branching, differentiation, and survival (Folkman, 2002; Spar-2004) . A large number of studies have demonstrated that tumann and Bar-Sagi, 2004) . For example, VEGF secreted by tumor cells secrete angiogenic growth factors to stimulate EC mor cells specifically binds to its receptors, VEGF receptors 1 proliferation and to induce angiogenesis. Among them, vascuand 2, in ECs (Ferrara et al., 2004) . Several important signaling lar endothelial growth factor (VEGF) is one of the most potent pathways, including mitogen-activating protein kinase (MAPK)/ angiogenic factors, and it is overexpressed in many human extracellular signal-regulated kinase (ERK) and phosphoinositol cancers (Jung et al., 2002) . Targeting VEGF for human cancer therapy has shown promise in the treatment of colorectal can-3-kinase (PI3K)/Akt, have been found to be induced by angio-
S I G N I F I C A N C E
Angiogenesis plays a critical role in human tumor growth and development. It is well known that tumor cells can stimulate angiogenesis by secreting proangiogenic factors such as vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8). However, targeting these factors in human cancer therapy has not been very effective, suggesting that other factors or components may also play a critical role in tumor angiogenesis. In this study, we show that tumor-associated growth factors stimulate the direct interaction between tumor cells and ECs via MAPK and Notch signaling pathways, thereby promoting tumor angiogenesis and tumor growth. Our findings underscore the importance of the direct interplay between tumor cells and ECs in tumor angiogenesis, providing a target for antiangiogenic therapy.
genic growth factors in ECs (Shaulian and Karin, 2002) . Activation of these pathways can promote the migration, proliferation, differentiation, and survival of ECs (Jung et al., 2002) . Recently, genetic studies have found that Notch signaling plays a critical role in vascular formation during early embryonic development (Xue et al., 1999; Krebs et al., 2000; Lawson et al., 2002; Krebs et al., 2004; Gale et al., 2004; Duarte et al., 2004) . Notch was initially identified as a neurogenic gene in Drosophila (Artavanis-Tsakonas et al., 1999) . Extensive studies have demonstrated that the Notch signaling pathway is highly conserved and plays a critical role in the specification of cell fate during development. In human, there are four notch receptor genes (Notch1 to Notch4) and five ligands, two jagged genes (jagged1 and jagged2), and three delta genes (delta-like1, delta-like3, and delta-like4) . Notch signaling is triggered by the direct interaction of cells expressing Notch receptors with cells that express Notch ligands at their surface. Upon Notch receptor-ligand binding, the Notch intracellular domain (Notch-ICD) is cleaved from the membrane by γ-secretase and other putative Notch processing enzymes. Subsequently, Notch-ICD is translocated to the nucleus, where it binds to RBPJκ [the mammalian homolog of Su (H), also known as CBF1 or CSL] to activate transcription of Notch target genes (Lindsell et al., 1995; Kato et al., 1997; Mumm et al., 2000) . Importantly, Notch ECs (Villa et al., 2001; Liu et al., 2003 the past decades (Wong et al., 1996; Patel et al., 2001 ; Foras-
The capillary-like sprouts were counted from five random microscopic fields (×200) and averaged. The assays were performed in duplicate, and tiere et al. Mao et al., 2004) . The molecular mechanisms the results represent mean values ± SD (error bars) from three independent that control the development and progression of HNSCC are experiments. Student's t test was performed to determine statistical signifinot fully understood. It is known that the MAPK signaling pathcance. *p < 0.01, EC + SCC9/H versus EC + CM, EC + SCC9, or EC. Scale way has been chronically activated in HNSCC (Patel et al., bar, 50 m. 2001; Mao et al., 2004) . Several growth factors and their recep-C: HGF induced Jagged1 by microarray. Microarray was performed as described previously (Zeng et al., 2002b c-Met, have also been found to be associated with HNSCC
(1:1000) by Western blot analysis. For loading control, the membranes were stripped and reprobed with anti-α-tubulin (1:7500).
development and progression (Patel et al., 2001; Zeng et al., 2002a) . All these growth factors can potently promote SCC cell proliferation by activating the MAPK signaling pathway. Also, the activation of MAPK by these growth factors induced SCC HGF stimulated SCC cells to release angiogenic factors to cells to secrete proangiogenic factors to promote tumor angiostimulate endothelial differentiation, thereby promoting tumor genesis (Bancroft et al., 2001) . Recently, we have found that angiogenesis. Because tumor angiogenesis involves multiple HGF potently stimulated the MAPK signaling pathway to profactors, including ECs, extracellular matrix, and tumor cells, a mote SCC cell survival (Zeng et al., 2002a; Zeng et al., 2002b) .
growth factor-reduced Matrigel model system for endothelial In this study, we identified that MAPK activated by growth facdifferentiation was utilized (Kumar et al., 2004; Liu et al., 2003) . tors including HGF initiated a novel signaling crosstalk beIn this model system, upon proangiogenic stimulation, ECs tween SCC cells and ECs that promoted tumor angiogenesis proliferate, migrate, and organize into capillary-like sprouts that and tumor growth.
mimic stages in the development of microvessels in vivo. As shown in Figures 1A and 1B Figure S1 in the Supplemental Data available with this article online). While other factors might be involved in the enhancement of network formation, our findings led us to examine whether the direct interaction between tumor cells and ECs stimulated a signaling cascade to promote angiogenesis. Previously, we generated a gene expression profile induced by HGF in SCC cells using microarray (Zeng et al., 2002b) . By searching our database, interestingly, although secreted angiogenic factors such as interleukin-8 (IL-8) were upregulated, we found that Jagged1 was strongly induced by HGF ( Figure 1C ). Jagged1 is a ligand for Notch proteins whose signaling plays a critical role in the specification of cell fate through local cell interactions. Since ECs express Notch receptors (Villa et al., 2001; Shawber and Kitajewski, 2004) , the induction of Jagged1 in SCC cells might activate the Notch signaling pathway in ECs. To confirm our microarray data, we examined whether Jagged1 expression was induced by HGF in SCC cells by Western blot analysis. As shown in Figure 1D , upon HGF treat- analysis (Zeng et al., 2002a) . Since AP-1 is a major effector of the MAPK signaling pathway (Shaulian and Karin, 2002) , we also examined whether the inhibition of AP-1 activity suppressed Jagged1 expression using SCC cells expressing the found to be overexpressed in human HNSCC (Mao et al., dominant-negative mutant of c-Jun, TAM-67. Previously, we 2004) . As shown in Figure 3A , the treatment of EGF or TGFα have demonstrated that TAM-67 was able to inhibit AP activapotently induced the activation of ERK in SCC14A cells as well tion induced by HGF in SCC cells (Zeng et al., 2002b) . To rule as other SCC cells, suggesting that the EGFR functionally out clonal variation, we utilized retrovirus-mediated transductransduced the MAPK signaling cascade in SCC cells. Simition to generate SCC9 and SCC14A cells that stably expressed larly, the expression of Jagged1 was significantly induced in TAM-67 (Figures 2E and 2F, top panel) . While Jagged1 was these SCC cells by EGF or TGFα ( Figure 3B ). Moreover, the induced in control SCC cells following HGF treatment, the ininhibition of MAPK, but not Akt, also suppressed Jagged1 exduction of Jagged1 was suppressed in SCC cells expressing pression in SCC14A cells and other cells ( Figure 3C ; data not TAM-67 (Figures 1E and 1F, bottom panel) . Consistently, we shown). Taken together, the expression of Jagged1 can be infound that two close AP-1 binding sites at positions −2488 and duced by common tumor-associated growth factors that acti-−2616 were present in the region of the jagged1 promoter. Our vate the MAPK signaling pathway. chromatin immunoprecipitation (ChIP) assays found that the AP-1 components c-Jun and c-Fos were recruited to this rePromotion of endothelial capillary-like sprout formation gion following HGF stimulation ( Figure S2 ).
by Jagged1-expressing SCC cells through activating We also directly examined whether the activation of the Notch signaling MAPK signaling pathway by EGF or TGFα could induce JagNext, we examined whether the induction of Jagged1 in SCC cells had a functional role in endothelial differentiation. Since ged1 expression in SCC cells. Importantly, EGFR has been Since the expression of Jagged1 might activate the Notch signaling pathway in adjacent SCC cells, it was possible that the Notch-inducible genes in SCC cells stimulated endothelial differentiation via a paracrine mechanism. To rule out this possibility, we overexpressed the constitutively activated Notch-ICD in SCC9 cells ( Figure 4E ). It is well known that, upon ligand binding, the Notch-ICD is cleaved and then moved to the nucleus, where it interacts with RBPJκ to activate gene expression. Previously, there were many studies that have demonstrated that Notch-ICD expression phenocopied Notch signaling (Lindsell et al., 1995; Kato et al., 1997; Mumm et al., 2000) . In contrast to SCC9/Jag cells, Notch-ICD-expressing SCC9 cells did not significantly enhance endothelial sprout formation in the Matrigel compared with coculture of ECs with SCC9/V cells ( Figures 4C and 4D ). The results suggest that the activation of the Notch signaling pathway in ECs, but not in SCC cells, was critical for endothelial sprout and network formation. The luciferase reporter assay confirmed that the overexpression of Notch-ICD stimulated transcription.
Next, we directly determined whether the endothelial sprout formation was directly dependent on the activation of the Notch signaling pathway in ECs. Thus, we utilized a highly specific γ-secretase inhibitor (γ-SI) to inhibit the Notch cleavage and activation (Dale et al., 2003) in the coculture of ECs and SCC9/Jag cells. As shown in Figure 4F , γ-SI strongly suppressed SCC9/Jag cell-induced endothelial network formation. In contrast, we found that γ-SI did not inhibit the proangiogenic factor IL-8-induced endothelial network formation ( Figure S3 ), RBPJκ is a major effector of the Notch signaling pathway. As shown in Figure 4H , overexpression of DN-Su(H) in SCC9/Jag cells did not have significant effects on endothelial sprout formation in our coculture assay. In sharp contrast, overexpres-HGF, EGF, or TGFα also induced SCC cells to secrete angiosion of DN-Su(H) in ECs totally abolished SCC9/Jag cellgenic growth factors (Mao et al., 2004) , it was critical to deterinduced network formation. Additionally, we found that the mine whether the Jagged1-expressing SCC cells alone was overexpression of Notch-ICD in ECs also promoted the sprout capable of inducing endothelial sprout formation by activating formation in the Matrigel, which could not be inhibited by Notch signaling in ECs. We utilized retrovirus-mediated trans-γ-SI or soluble Jagged1-conditioned media ( Figure S4 ). Taken duction to stably express Jagged1 in SCC9 cells in which the together, these results suggest that Jagged1-expressing SCC level of endogenous Jagged1 was undetectable. Western blot cells were capable of initiating a crosstalk with ECs through analysis demonstrated that Jagged1-expressing SCC9 cells activating the Notch signaling pathway, thereby inducing endo-(SCC9/Jag) and control cells (SCC9/V) were generated (Figure thelial capillary-like sprout networks. 4A). The coculture of ECs with SCC9/Jag cells, but not with SCC9/V cells, potently activated the Notch-dependent luciferEndothelial capillary-like network formation induced ase reporter in ECs ( Figure 4B ), confirming that Jagged1-by endogenous Jagged1-expressing SCC cells expressing SCC9 cells could functionally trigger the Notch sigAs demonstrated in Figure 3B , SCC14A cells expressed a high naling pathway in their neighboring cells. To determine whether basal level of endogenous Jagged1. Thus, we wondered Jagged1-expressing SCC cells stimulated the capillary-like whether the elevated endogenous Jagged1 would promote ennetwork formation, ECs were cocultured with SCC9/Jag cells dothelial differentiation in vitro. As shown in Figures 5A and or SCC9/V cells on the Matrigel. As shown in Figures 4C and 5B, like SCC9/Jag cells, coculture of ECs with SCC14A cells 4D, SCC9/Jag cells induced 4-fold more endothelial sprouts strongly promoted endothelial network formation in the Matrithan SCC-9/V cells. Moreover, these endothelial sprouts ingel. To determine whether SCC14A cell-stimulated endothelial sprout formation was dependent on the Notch signaling pathduced by SCC9/Jag cells formed a well-connected network.
way, we added γ-SI to the coculture. As shown in Figures 5A and 5B, γ-SI totally abolished endothelial tube formation induced by SCC14A. The luciferase assay confirmed that γ-SI inhibited Notch-dependent transcription induced by SCC14A cells ( Figure 5C ). Also, we utilized soluble Jagged1, which was able to be secreted and to interfere with the interaction between the normal Notch receptor and ligand (Wu et al., 2001 ). SCC14A cells were stably transduced with retroviruses expressing soluble Jagged1 (S-Jag). As shown in Figure 5D , the S-Jag proteins were detected not only in cell lysates but also in cell culture media, demonstrating that S-Jag was secreted in SCC14A cells. Moreover, S-Jag also inhibited Notch-dependent transcription induced by SCC14A cells ( Figure 5C ). Compared with SCC14A/V cells, the endothelial network formation was significantly reduced in coculture of ECs with SCC14A/ S-Jag cells (Figures 5A and 5B) . To further confirm our results, we also determined whether depletion of Jagged1 expression in SCC14A cells by siRNA inhibited sprout formation in our coculture assay. As shown in Figure 5E , Western blot analysis demonstrated that Jagged1 siRNA, but not luciferase siRNA, completely suppressed Jagged1 expression in SCC14A cells. While luciferase siRNA did not interfere with the endothelial sprout formation in our coculture assay, the depletion of Jagged1 expression in SCC14A potently suppressed the sprout formation induced by SCC14A cells ( Figure 5F ).
Finally, we also determined whether Jagged1 expressed in SCC9 cells was responsible for the capillary-like sprout formation in our coculture assay upon HGF stimulation. As shown in Figure 5G , Western blot analysis confirmed that Jagged1 siRNA, but not control luciferase siRNA, completely inhibited Jagged1 expression in SCC9 cells induced by HGF. Transfection of luciferase siRNA did not affect the sprout formation in our coculture assay upon HGF stimulation. The deletion of Jagged1 by siRNA strongly suppressed capillary-like sprout formation stimulated by HGF-treated SCC9 cells ( Figure 5H ). Moreover, as shown in Figure 5H , both S-Jag-conditioned me-A: SCC9 cells stably expressing Jagged1. SCC9 cells were transduced with retroviruses expressing Jagged1 or control vector. After selection, the stadia from SCC14A/S-Jag cells and γ-SI also abolished the ble clones were pooled and probed with anti-Jagged1. sal region of SCID mice, and tumor angiogenesis was examined by histology and immunostaining (Nor et al., 2001 ). First, we examined tumor angiogenesis at an early stage (3 weeks).
As shown in Figure 6A , the scaffold coimplanted with ECs and SCC9/Jag cells was more vascularized than that with ECs and SCC9/V cells. Along with tumor formation, immunostaining of human factor VIII, a marker for ECs, found that significantly more intratumoral blood vessels were induced in the scaffolds seeded with the combination of ECs with SCC9/Jag cells compared with SCC9/V cells ( Figures 6B and 6C) . After 6 weeks, scaffolds were retrieved, and the coimplants of ECs with SCC9/Jag cells exhibited more aggressive tumor growth than those with SCC9/V cells, as determined by tumor volume and size ( Figures 6D and 6E) . Finally, human factor VIII immunostaining also found that there were three times more blood vessels in tumors from the endothelial coimplants with SCC9/Jag cells than in those with SCC9/V cells ( Figure 6F ). During in vitro cell culture, we observed that both SCC9/V and SCC9/Jag cells grew at the similar rate. More specifically, the 5-bromodeoxyuridine (BrdU) incorporation assay indicated that the rate of DNA synthesis of both cells in vitro was identical ( Figures S5A-S5C ). It suggested that the different tumor growth rates from coimplants were unlikely due to the possibility that Jagged1 directly stimulated SCC cell proliferation. To determine whether the enhancement of tumor angiogenesis might affect the proliferation of SCC cells in vivo, tumor-bearing mice were injected with BrdU intraperitoneally, and BrdU uptakes in tumor cells were examined. Unlike in vitro, the immunostaining found that significantly greater numbers of BrdU-positive tumor cells (over 2-fold) were observed in tumors from coimplants of ECs with SCC9/Jag cells compared gether, these results from in vivo studies suggest that Jag-*p < 0.01, EC + SCC14A versus EC + SCC14A + γ-SI or EC + SCC14A/S-Jag. signaling components were found to be overexpressed in hu-F: The inhibition of Jagged1 expression suppressed the proangiogenic efman HNSCC by gene profiling (Leethanakul et al., 2000) . Thus, fects of SCC14A in coculture. SCC14A cells were transfected with Jagged1
ged1-expressing tumor cells can stimulate tumor angiogenesis
we further compared the level of Jagged1 expression in human siRNA or Luc siRNA for 36 hr. After treatment, Jagged1-or Luc siRNA-transfected SCC14A cells were cocultured with ECs for 24 hr. *p < 0.01, EC + HNSCC with normal epithelial tissues and dysplasias using the SCC14A/Luc siRNA versus EC + SCC14A/Jagged1 siRNA.
combination of high-density TMA and immunostaining. Repre-G: HGF-induced Jagged1 expression was inhibited by Jagged1 siRNA in SCC9 cells. SCC9 cells were transfected with Jagged1 or Luc siRNA (100 M) for 36 hr and then treated with HGF for 0, 1, 4, and 8 hr. The level of Jagged1 expression was examined by Western blot analysis. H: The inhibition of Notch signaling suppressed the proangiogenic effects S-Jag cells. *p < 0.01, EC + SCC9 + Luc siRNA + HGF versus EC + SCC9 + of SCC9 coculture upon HGF stimulation. SCC9 cells were transfected with Jagged1 or Luc siRNA for 36 hr and then treated with HGF for 4 hr. After HGF + Jagged1 siRNA, EC + SCC9 + HGF + γ-SI, or EC + SCC9 + HGF + S-Jag. The results represent mean ± SD (error bars) from three independent treatment, Jagged1-or Luc siRNA-transfected SCC9 cells were cocultured with ECs for 24 hr. HGF-treated SCC9 cells were also cocultured with ECs in experiments. Student's t test was performed to determine statistical significance. the presence of γ-SI or soluble Jagged1-conditioned media from SCC14A/ Figure 7 . Jagged1 expression is highly elevated and correlated with human microvessel formation in human HNSCC tissues A and B: Jagged1 expression is highly elevated in HNSCC. Human TMA sections were stained with anti-Jagged1 (1:50). The level of Jagged1 was scored based on staining intensity of normal or dysplastic epithelial cells Figure 6 . Jagged1-expressing SCC cells promote tumor angiogenesis and and tumor cells: 0 = negative; 1 = weak; 2 = moderate; 3 = strong. A total tumor growth in a nude mouse model of 350 samples (259 SCCs, 17 normal epithelial tissues, 18 dysplasias, and A: Coimplant of ECs with SCC9/Jag was highly vascularized in vivo. ECs 56 adjacent muscle and connective tissues) were scored. Of note, some and SCC9/Jag or SCC9/V cells were mixed with the Matrigel, seeded in tissue samples were lost during staining. The average scores were calcudifferent scaffolds, and then implanted in SCID mice. After 3 weeks, the lated from each group, and statistical significance was determined by the implants were harvested and photographed. Left: the coimplant of ECs Student's t test. Error bars represent standard deviation. *p < 0.01, dysplaand SCC9/Jag cells; right: the coimplant of ECs and SCC9/V cells. sias versus normal epithelial tissues; **p < 0.01, SCC versus dysplasias or B and C: Jagged1-expressing SCC cells enhanced tumor angiogenesis. normal epithelial tissues. Scale bar, 25 m. Coimplants of ECs and SCC9/Jag or SCC9/V cells were sectioned and C: Jagged1 expression was correlated with human microvessel formation stained with hematoxylin and eosin (HE) or anti-factor VIII (1:200). The in HNSCC. TMA sections were stained with anti-factor VIII (1:200) and antimicrovessels were counted from five random fields (×200) and averaged. Jagged1 (1:50), respectively. Scale bar, 25 m. The experiments were performed three independent times (five coimplants per group), and the results represent mean ± SD (error bars) from 15 coimplants per group. Student's t test was performed to determine statistical significance. *p < 0.01. L, low magnification, scale bar, 50 m; H, high sentative examples of staining for Jagged1 in normal epithelial magnification, scale bar, 25 m. D-F: Jagged1-expressing SCC cells promoted tumor angiogenesis and tutissues, dysplasias, and SCC are shown in Figure 7A . Mean mor growth. The experiments were performed as described in A, and scafJagged1 staining intensity was significantly increased in hufolds were harvested 6 weeks after implantation. After tumor volumes and man HNSCC compared with dysplasias and normal epithelial weights were measured, specimens were fixed, paraffin-embedded, and tissues (p < 0.01). Also, we observed that Jagged1 staining sectioned. Serial sections were stained with HE or polyclonal antibodies was modestly stronger in dysplasias than that in normal epitheagainst human factor VIII. The microvessels were counted from five random fields (×200) and averaged. Two independent experiments were perlial tissues (Figures 7A and 7B) . However, we did not find that formed (five coimplants per group), and the results represent mean ± SD there was significant difference in Jagged1 staining between (error bars) from ten coimplants per group. Statistical significance was declinical or pathological stages of HNSCC. To determine whether termined by the Student's t test. *p < 0.01. G: The promotion of BrdU uptake by SCC cells in tumors derived from the coimplants of endothelial cells and SCC9/Jag cells. The experiments were performed as described in A. Mice were injected with BrdU labeling reagents (10 ml/kg) intraperitoneally 2 hr before the scaffolds were retrieved.
formed (ten coimplants per group), and the results represent mean ± SD The sections were incubated with biotinylated anti-BrdU using the Zymed BrdU staining kit. The BrdU-positive cells were counted from five random (error bars) from 20 coimplants per group. Statistical significance was determined by the Student's t test. *p < 0.01. fields (×200) and averaged. Two independent experiments were per- Tissue microarray (TMA) sections were stained with anti-factor VIII and anti-Jagged1, respectively. The microvessel content was scored based on staining intensity and area of human factor VIII: + = weak; ++ = moderate; +++ = strong; ++++ = very strong. The level of Jagged1 was scored as described in Figures 7A and 7B . A total of 224 SCC samples that could be scored for both Jagged1 and factor VIII expression were utilized for our studies.
a
Pearson correlation coefficient analysis. p < 0.01; r = 0.65.
there was corelationship between Jagged1 expression and tuabolished proangiogenic effects of the SCC cell coculture upon HGF stimulation. Moreover, the depletion of the high basal level mor blood vessel formation in HNSCC tumor tissues, TMA was also stained with anti-factor VIII antibodies. Our representative of Jagged1 in unstimulated SCC cells also abolished the proangiogenic effects of the SCC cell coculture. Our results sugphotograph demonstrates that tumor blood vessel formation was significantly increased in tumors with higher expression of gest that contact-dependent Notch signals play a critical role in endothelial differentiation. However, our findings did not rule Jagged1 compared with tumors with low expression of Jagged1 ( Figure 7C ). Interestingly, in some samples, we observed out the possible contribution of the proangiogenic effects of IL-8 or other secreted proangiogenic factors. In fact, we obthat some invasive SCC cells were surrounded by factor VIIIpositive cells. Moreover, the statistical analysis also found that served that conditioned media from HGF-treated SCC cells modestly induced endothelial differentiation in vitro. After the Jagged1 expression was correlated with blood vessel intensity in HNSCC tumor tissues (Pearson correlation coefficient; p < conditioned medium was concentrated, we found that it could more strongly promote endothelial differentiation (data not 0.01) ( Table 1) . Our results suggest that HNSCC cells may utilize the Notch signaling pathway to promote tumor angiogenshown), suggesting that secreted proangiogenic factors function in a dose-dependent manner. Importantly, we found that esis in vivo and that the level of Jagged1 expression may be associated with the development of HNSCC.
Jagged1 expression was also induced by other growth factors, including TGFα and EGF, via the activation of MAPK, suggesting that the crosstalk between tumor cells and ECs could be Discussion triggered by these growth factors. Genetic studies have demonstrated that there is a crosstalk Our studies demonstrate that contact-dependent Notch signalbetween the Notch and MAPK signaling pathways in cell fate ing triggered by the MAPK signaling pathway plays a critical determination using a model system of C. elegans and Drorole in tumor angiogenesis. Although some early works resophila (Tsuda et al., 2002; Kumar and Moses, 2001 ; Shaye ported that Notch signaling might inhibit angiogenesis, reand Greenwald, 2002; Yoo et al., 2004) . For example, Berset cently, elegant genetic and molecular studies suggested that Notch signaling plays a critical role in angiogenesis during deet al. (2001) and Yoo et al. (2004) have demonstrated that the Notch signaling pathway inhibited the MAPK signaling pathway velopment (Krebs et al., 2000; Lawson et al., 2002; Duarte et al., 2004; Krebs et al., 2004; Gale et al., 2004) . In Notch or through the induction of multiple negative regulators of MAPK during C. elegans vulval development (Shaye and Greenwald, Jagged1 mutant mouse embryos, vasculogenic formation of the head, yolk sac, and intersomitic vessel was unaffected. In-2002) . On the contrary, it was also found that the EGFR-MAPK activation could downregulate Notch via endocytosis during C. stead, there was a failure to reorganize these rudimentary vessels into large vessels and branching capillaries (Xue et al., elegans vulval development. These studies suggest that the coordination of signals from different pathways must be pre-1999; Krebs et al., 2000) . These results suggest that Notch signaling may not be required for vasculogenesis but is essential cisely integrated for cell fate specification during development. It has been found that Notch can function either as a tumor for physiological angiogenesis. Currently, how Notch signaling in angiogenesis is activated during development is not clear.
suppressor or as an oncogene, depending on the cellular context (Maillard and Pear, 2003) . According to the results from C. Our results suggest that the upregulation of Jagged1 expression in SCC cells may provide a unique mechanism to control elegans, the inhibition of MAPK by Notch provides a reasonable explanation for Notch-mediated tumor suppression in neovascularization. The Jagged1-expressing SCC cells may not only promote, but also guide angiogenesis, thus providing some cases. However, it is possible that the principal findings elucidated nutrients to support the development and growth of HNSCC.
Importantly, we identified a novel mechanism of tumor angiby studying C. elegans vulval development may not be applicable to human cancer development. Studies by Weijzen et al. ogenesis mediated by the crosstalk between tumor cells and ECs via the Notch and MAPK signaling pathways. Several (2002) have found that Notch was also activated in Ras-transformed cells in which MAPK was constitutively activated. The secreted proangiogenic factors, including IL-8 and VEGF, have been found to be induced by the MAPK or Akt signaling pathinhibition of Notch signaling suppressed Ras-mediated transformation. Mailhos et al. (2001) have reported that Dll4 expresways (Jung et al., 2002; Sparmann and Bar-Sagi, 2004) . Interestingly, the knockdown of Jagged1 expression significantly sion was induced during tumor angiogenesis in a mouse model Matrigel in each well. The chambers were then incubated at 37°C for 24 hr.
In our immunostaining studies, we did frequently observe that
After incubation, the slides were fixed with methanol and stained with DiffQuick solution II (Sigma). The slides were examined, and the sprouts were Jagged1-expressing SCC cells were surrounded by microvescounted from five random fields under a microscope (×200).
sels. Compared with normal epithelial tissues, Jagged1 was were mixed with the Matrigel and loaded into scaffolds. Four-week-old female SCID mice were purchased from Taconic and anesthetized with ketaExperimental procedures mine and xylazine. One scaffold containing the mixture of ECs and SCC9/ Jag cells and another with ECs and SCC9/V cells were implanted subcutaCell culture, retroviral infection, and reagents neously on the left and right flank region of each mouse, respectively. Three SCC cell lines were derived from patients with HNSCC in Dr. Thomas Caror six weeks after transplantation, mice were sacrificed, and the scaffolds ey's laboratory at the University of Michigan and were cultured in DMEM were retrieved, immediately measured with calipers, and weighed in an supplemented with 10% FBS from Invitrogen (Grand Island, NY). SCC1 was electronic balance. Afterwards, the scaffolds were fixed with 10% buffered derived from patients with HNSCC in the floor of mouth. SCC5, SCC9, formalin and embedded in paraffin. The specimens were sectioned at 4 M and SCC14A were derived from a patient with HNSCC in the oropharynx for histological examination (Nor et al., 2001) . For BrdU labeling, mice were (Takebayashi et al., 2000) . The human dermal microvascular ECs (cat. CCinjected with BrdU labeling reagents (10 ml/kg; cat. 103; Zymad) 2 hr before 0288) were purchased from Cambrex (Walkersville, MD) and were cultured the scaffolds were retrieved. The care and transplantation of mice was in in EGM-2 medium supplemented with growth factors (cat. CC-4147; Camaccordance with the guidelines of the University of Michigan Committee on brex). The chemical inhibitors U0126 (cat. 9903) and LY294002 (cat. 9901) Use and Care of Animals (UCUCA). were purchased from Cell Signaling (Beverly, MA). The specific γ-secretase inhibitor IX (cat. 565770) was purchased from Calbiochem (La Jolla, CA).
Immunohistochemistry The method for retroviral infection is provided in the Supplemental Data.
Human HNSCC high-density TMA was prepared by the University Michigan Head and Neck SPORE Tissue Core with Institutional Review Board apTransfection and luciferase reporter assay proval. Samples (n = 400) from a total of 102 cases with different clinical Transient transfections were performed by lipofectamine (cat. 18324; Invitand pathological stages were arrayed in slides. At least three tissue cores rogen) according to the manufacturer's protocol. ECs were plated in a six-(0.6 mm diameter) from tumor tissues were sampled from each case, and well plate overnight and then cotransfected with the Notch luciferase reporin some cases three tissue cores from adjacent normal tissues were samter pGA981-6 (Wu et al., 2001 ) and pRL-TK Renilla luciferase reporter as an pled. The TMAs covered the whole spectrum of HNSCC, including normal internal control. Twenty-four hours after transfection, the transfected ECs epithelial tissues, adjacent normal connective tissues, dysplasias, and priwere cocultured with SCC/Jag or SCC/V cells for additional 24 hr. Lucifermary SCC and metastatic SCC. The detailed methods for immunostaining ase activities were measured using a dual luciferase system (Promega) as and scoring are described in the Supplemental Data. described previously (Zeng et al., 2002a) .
Western blot and Northern blot analyses
Supplemental data SCC cells were plated in 10 cm tissue culture dishes the day before treatment. Cells were treated with HGF (40 ng/ml; R&D Systems) for the indiThe Supplemental Data include Supplemental Experimental Procedures and six figures and can be found with this article online at http://www. cated times. Cells were harvested, and whole-cell extracts were prepared. Western blot analysis was performed as described in the Supplemental cancercell.org/cgi/content/full/8/1/13/DC1/.
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